Creative Planning Exact Sciences Corp Call Options Transaction History

Creative Planning

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 10, 2021	BUY	$90.24 - $124.05 $135,360 - $186,075	1,500 Added 187.5%	2,300 $8,000
Q2 2021 Aug 04, 2021	BUY	$93.66 - $139.27 $37,464 - $55,708	400 Added 100.0%	800 $8,000
Q3 2020 Nov 05, 2020	BUY	$72.92 - $102.01 $21,876 - $30,603	300 Added 300.0%	400 $4,000
Q1 2018 Apr 18, 2018	BUY	$39.82 - $57.53 $3,982 - $5,753	100 New	100 $0

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.